A Phase Ia/Ib Study of HW221043 in Participants With Advanced Solid Tumors
NCT07719920
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
99
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
HW221043 Tablets
Sponsor
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.